Shankar Musunuri's most recent trade in Ocugen Inc was a trade of 1,827,485 Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 2, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 1,827,485 | 1,827,485 | - | - | Option (Right to Buy) | |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.89 per share. | 02 Jan 2025 | 177,146 | 1,832,723 (3%) | 0% | 0.9 | 158,457 | Common Stock |
Ocugen Inc | Musunuri Shankar | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.65 per share. | 03 Jan 2024 | 180,204 | 2,009,869 (3%) | 0% | 0.7 | 117,673 | Common Stock |
Ocugen Inc | Musunuri Shankar | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 492,126 | 492,126 | - | - | Option (Right to Buy) | |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.28 per share. | 17 Jan 2023 | 100,000 | 2,227,950 (4%) | 0% | 1.3 | 128,000 | Common Stock |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 100,000 | 326,543 | - | - | Option (Right to Buy) | |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.51 per share. | 17 Jan 2023 | 100,000 | 2,327,950 (4%) | 0% | 0.5 | 51,000 | Common Stock |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 1,771,654 | 1,771,654 | - | - | Option (Right to Buy) | |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 1,475,410 | 2,227,950 (4%) | 2% | 0 | Common Stock | |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.08 per share. | 03 Jan 2023 | 100,000 | 2,190,073 (4%) | 0% | 1.1 | 108,000 | Common Stock |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.33 per share. | 03 Jan 2023 | 100,000 | 2,290,073 (4%) | 0% | 0.3 | 33,000 | Common Stock |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2023 | 100,000 | 529,764 | - | - | Option (Right to Buy) | |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.25 per share. | 03 Jan 2023 | 37,877 | 2,190,073 (4%) | 0% | 1.2 | 47,346 | Common Stock |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.51 per share. | 16 Dec 2022 | 95,809 | 848,349 (1%) | 0% | 0.5 | 48,863 | Common Stock |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2022 | 95,809 | 426,543 | - | - | Option (Right to Buy) | |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.43 per share. | 16 Dec 2022 | 95,809 | 752,540 (1%) | 0% | 1.4 | 137,007 | Common Stock |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.66 per share. | 14 Oct 2022 | 100,000 | 752,540 (1%) | 0% | 1.7 | 166,000 | Common Stock |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Oct 2022 | 100,000 | 522,352 | - | - | Option (Right to Buy) | |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.51 per share. | 14 Oct 2022 | 100,000 | 852,540 (1%) | 0% | 0.5 | 51,000 | Common Stock |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.33 per share. | 14 Jul 2022 | 150,000 | 902,540 (1%) | 0% | 0.3 | 49,500 | Common Stock |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2022 | 150,000 | 629,764 | - | - | Option (Right to Buy) | |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 2.72 per share. | 14 Jul 2022 | 150,000 | 752,540 (1%) | 0% | 2.7 | 408,000 | Common Stock |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.33 per share. | 13 May 2022 | 125,000 | 877,540 (1%) | 0% | 0.3 | 41,250 | Common Stock |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.92 per share. | 13 May 2022 | 125,000 | 752,540 (1%) | 0% | 1.9 | 240,000 | Common Stock |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2022 | 125,000 | 779,764 | - | - | Option (Right to Buy) | |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 2.65 per share. | 16 Mar 2022 | 81,823 | 752,540 (1%) | 0% | 2.7 | 216,831 | Common Stock |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2022 | 81,823 | 904,764 | - | - | Option (Right to Buy) | |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.33 per share. | 16 Mar 2022 | 81,823 | 834,363 (1%) | 0% | 0.3 | 27,002 | Common Stock |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 3.74 per share. | 14 Feb 2022 | 90,000 | 752,540 (1%) | 0% | 3.7 | 336,600 | Common Stock |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2022 | 90,000 | 986,587 | - | - | Option (Right to Buy) | |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.33 per share. | 14 Feb 2022 | 90,000 | 842,540 (1%) | 0% | 0.3 | 29,700 | Common Stock |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 1,253,299 | 1,253,299 | - | - | Option (Right to Buy) | |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 346,540 | 752,540 (1%) | 0% | 0 | Common Stock | |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Nov 2021 | 197,000 | 197,000 | - | - | Option (Right to Buy) | |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 8.04 per share. | 16 Nov 2021 | 115,000 | 1,260,299 (2%) | 0% | 8.0 | 924,600 | Common Stock |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.15 per share. | 01 Nov 2021 | 115,367 | 406,000 (0%) | 0% | 14.1 | 1,632,443 | Common Stock |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2021 | 115,367 | 622,352 | - | - | Option (Right to Buy) | |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.51 per share. | 01 Nov 2021 | 115,367 | 521,367 (0%) | 0% | 0.5 | 58,837 | Common Stock |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 9.80 per share. | 15 Oct 2021 | 125,000 | 406,000 (0%) | 0% | 9.8 | 1,225,000 | Common Stock |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2021 | 125,000 | 1,076,587 | - | - | Option (Right to Buy) | |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.33 per share. | 15 Oct 2021 | 125,000 | 531,000 (1%) | 0% | 0.3 | 41,250 | Common Stock |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 7.52 per share. | 15 Sep 2021 | 125,000 | 406,000 (0%) | 0% | 7.5 | 940,000 | Common Stock |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2021 | 125,000 | 1,201,587 | - | - | Option (Right to Buy) | |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.33 per share. | 15 Sep 2021 | 125,000 | 531,000 (1%) | 0% | 0.3 | 41,250 | Common Stock |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2021 | 22,800 | 1,326,587 | - | - | Option (Right to Buy) | |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.98 per share. | 07 Jun 2021 | 22,800 | 406,000 (0%) | 0% | 11.0 | 250,344 | Common Stock |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.33 per share. | 07 Jun 2021 | 22,800 | 428,800 (0%) | 0% | 0.3 | 7,524 | Common Stock |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.94 per share. | 07 Jun 2021 | 7,758 | 406,000 (0%) | 0% | 10.9 | 84,873 | Common Stock |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2021 | 7,758 | 1,349,387 | - | - | Option (Right to Buy) | |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.33 per share. | 07 Jun 2021 | 7,758 | 413,758 (0%) | 0% | 0.3 | 2,560 | Common Stock |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.24 per share. | 03 May 2021 | 195,809 | 406,000 (0%) | 0% | 14.2 | 2,788,320 | Common Stock |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2021 | 195,809 | 737,719 | - | - | Options (Right to Buy) | |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.51 per share. | 03 May 2021 | 195,809 | 601,809 (1%) | 0% | 0.5 | 99,863 | Common Stock |
Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2021 | 1,757,000 | 1,757,000 | - | - | Option (Right to Buy) |